Latest Breaking News On - Lyra therapeutics inc - Page 8 : vimarsana.com

Transmucosal Drug Delivery Pipeline Research Report 2023: Formulate Effective R&D Strategies with Key Insights

/PRNewswire/ The "Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key.

United statesIsrael generalNew south walesLaura woodHarm reduction therapeutics incHebrew university of jerusalemProducts under developmentBespak europe ltdInternational partnershipUniversity of the witwatersrandLyra therapeutics incKytogenics pharmaceuticals incGrunenthal ltdFerring pharmaceuticalsRenown pharmaceuticals pvt ltdAtossa therapeutics inc

Lyra Therapeutics to Present at William Blair Virtual Biotechnology Conference

Lyra Therapeutics to Present at William Blair Virtual Biotechnology Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEllen cavaleriMaria palasisLyra therapeutics incChief executive officerWilliam blair virtual biotechnology conferenceBiotech breakthroughsCommercial successInvestor relations

Lyra Therapeutics, Inc (NASDAQ:LYRA) Sees Significant Increase in Short Interest

Lyra Therapeutics, Inc. (NASDAQ:LYRA – Free Report) saw a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 447,700 shares, a growth of 56.8% from the May 31st total of 285,500 shares. Based on an average daily volume of 113,900 shares, the days-to-cover ratio is […]

United statesPerceptive advisors llcLyra therapeutics company profileYork mellon corpRenaissance technologiesLyra therapeutics incVanguard group incNbvm gp llcAmerica corpLyra therapeuticsFree reportDirector perceptive advisors llcNew york mellon corpSigma advisersVanguard groupLyra therapeutics daily

Reviewing Lyra Therapeutics (NASDAQ:LYRA) and Intelligent Bio Solutions (NASDAQ:INBS)

Lyra Therapeutics (NASDAQ:LYRA – Get Rating) and Intelligent Bio Solutions (NASDAQ:INBS – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk. Profitability This table compares Lyra Therapeutics and Intelligent […]

United statesNew yorkLyra therapeutics incLife science biosensor diagnostics pty ltdIntelligent bio solutionsIntelligent bio solutions incBiomedical incLyra therapeuticsGet ratingIntelligent bio solutionBio solutionsGiven lyra therapeuticIntelligent bioBio solutions incSaliva glucose biosensorLife science biosensor diagnostics pty

Lyra Therapeutics, Inc (NASDAQ:LYRA) Major Shareholder Purchases $4,387,160 88 in Stock

Lyra Therapeutics, Inc. (NASDAQ:LYRA – Get Rating) major shareholder Nbvm Gp, Llc purchased 1,805,416 shares of the firm’s stock in a transaction dated Wednesday, May 31st. The shares were bought at an average price of $2.43 per share, with a total value of $4,387,160.88. Following the purchase, the insider now owns 2,521,745 shares in the […]

United statesRenaissance technologiesLyra therapeutics company profileNbvm gp llcLyra therapeutics incVanguard group incAmerica corpEnsign peak advisors incLyra therapeuticsGet ratingPeak advisors incTwo sigma advisersSigma advisersLyra therapeutics dailyNasdaq lyraInsider trading